首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

2049571

病毒過濾市場規模、佔有率、趨勢和預測：按產品、應用、最終用途和地區分類，2026-2034 年

Virus Filtration Market Size, Share, Trends and Forecast by Product, Application, End Use, and Region, 2026-2034

出版日期: 2026年05月01日 | 出版商:

IMARC | 英文 136 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

2025年全球病毒過濾市場規模達51億美元。展望未來，IMARC Group預測，該市場從2026年到2034年將以7.73%的複合年成長率成長，到2034年達到101億美元。市場成長的主要促進因素包括全球健康危機日益頻繁、生物製藥大規模生產需求在緊迫的時間表下不斷成長，以及對新藥、治療方法和疫苗研發投入的增加。

病毒過濾是生物製藥生產過程中至關重要的一步，旨在確保包括疫苗、抗體和生物製藥在內的藥品的安全性和純度。此方法用於去除可能危害人體健康的病毒污染物。對於注射劑的生產而言，這一點尤其重要，因為注射劑需要極高的純度標準，需要直接注入人體。通常使用具有特定孔徑的專用薄膜過濾器來捕獲和去除病毒。這些過濾器旨在有效捕獲病毒顆粒，同時允許目標產品通過。該工藝在實施前經過嚴格的驗證，並定期進行測試以確認其有效性。此外，它也是藥品生產中可靠的安全措施，能夠提高產品安全性並確保符合法規要求。

全球市場的主要驅動力是頻繁發生的全球性健康危機，例如流行病和病毒的廣泛爆發。這凸顯了此過濾技術對於確保醫療用品和藥品安全的重要性。在此類時期，對疫苗和其他治療藥物的需求急劇增加。這種需求要求在嚴格的時間安排下大規模生產生物製藥產品，同時確保安全性。因此，這對市場產生了積極影響。此外，生物製藥行業契約製造組織 (CMO) 的興起也是推動市場成長的另一個重要因素。此外，對新藥、治療方法和疫苗研發投入的增加，也為市場提供了強力的支持，因為這些研發過程本身就需要這些製程來確保安全性和合規性。

病毒過濾市場的發展趨勢與促進因素：

生物製藥需求不斷成長

病毒過濾產業的主要市場驅動力之一是生物製藥（例如單株抗體、重組蛋白和疫苗）需求的不斷成長。這些複雜的分子通常來自活細胞，因此極易受到病毒污染。此外，包括癌症、糖尿病和自體免疫疾病在內的慢性疾病盛行率的上升也對市場產生了影響。這種需求的成長給生產商帶來了壓力，他們需要生產符合嚴格安全和品質標準的生物製藥產品。病毒過濾在此背景下至關重要，因為它對於確保這些產品的純度和安全性至關重要。監管機構已製定了嚴格的病毒去除指南，進一步凸顯了這些技術的重要性。隨著越來越多的生物製藥產品進入市場或進行臨床試驗，對病毒過濾服務的需求也相應增加，從而推動了該行業的發展。

技術和研究的不斷進步

過濾膜和過濾方法領域的技術進步正顯著推動病毒過濾產業的成長。這促成了更有效率、擴充性且更具成本效益的過濾系統的開發，使製藥公司能夠輕鬆地將這些解決方案整合到現有生產線中。奈米技術和材料科學的創新使過濾器擁有更高的效率和更優異的處理能力，從而實現更快、更可靠的病毒去除。隨著過濾技術研發的不斷深入，該領域的企業正在擴大這些技術的應用範圍。這項技術進步正在提升製藥生產的標準，並成為全球市場強勁的驅動力。

加強對監管合規和品質保證的重視。

對於病毒過濾產業而言，遵守監管標準既是必要條件，也是市場發展的驅動力。監管機構已製定關於生物製藥病毒安全性的具體指南。這些指南通常要求採用多種病毒去除工藝，包括生物來源過濾。滿足這些監管要求對於製藥公司獲得產品核准和維護市場信譽至關重要。鑑於病毒污染的嚴重後果，從產品上市延遲到法律責任，對監管合規性的日益重視是推動病毒過濾技術應用的重要動力。此外，對品質保證的日益重視也惠及整個產業，並已成為生物製藥生產價值鏈中不可或缺的環節。

The global virus filtration market size reached USD 5.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 10.1 Billion by 2034, exhibiting a growth rate (CAGR) of 7.73% during 2026-2034. The rising occurrences of global health crises, the growing need for mass production of biopharmaceuticals under tight schedules, and the growing investments in the development of new medicines, therapies, and vaccines are among the key factors driving the market growth.

Virus filtration is a critical step in the biopharmaceutical manufacturing process aimed at ensuring the safety and purity of medicinal products, including vaccines, antibodies, and biologics. This method is employed to remove viral contaminants that could be harmful to human health. It is especially essential in the production of parenteral medications, which are introduced directly into the body and thus require high purity standards. Typically, specialized membrane filters with defined pore sizes are used to capture and remove viruses. These filters are designed to allow the passage of the desired product while effectively trapping viral particles. The process is rigorously validated before implementation, and periodic testing is performed to confirm its effectiveness. Furthermore, it serves as a robust safeguard in pharmaceutical manufacturing, enhancing product safety and compliance with regulatory requirements.

The global market is majorly driven by the escalating occurrence of global health crises such as pandemics and widespread viral outbreaks. This highlights the importance of this filtration technique to ensure the safety of medical supplies and pharmaceuticals. During such times, there is an exponential increase in the demand for vaccines and other therapeutic agents. This demand necessitates the mass production of biopharmaceuticals under tight schedules, without compromising on safety. Therefore, this is positively influencing the market. Along with this, the rise of contract manufacturing organizations (CMOs) in the biopharmaceutical industry is another significant factor contributing to the growth of the market. In addition, the escalating investments in the development of new medicines, therapies, and vaccines, which inherently require these processes for safety and compliance are also significantly supporting the market.

Virus Filtration Market Trends/Drivers:

Increasing demand for biopharmaceuticals

One of the significant market drivers for the virus filtration industry is the growing demand for biopharmaceuticals such as monoclonal antibodies, recombinant proteins, and vaccines. These complex molecules are often derived from living cells, making them susceptible to viral contamination. Along with this, the rising prevalence of chronic diseases, including cancer, diabetes, and autoimmune disorders is impacting the market. This increase in demand places a burden on manufacturers to produce biopharmaceuticals that meet stringent safety and quality criteria. Virus filtration becomes an indispensable step in this scenario, as it is crucial for ensuring the purity and safety of these products. Regulatory bodies are imposing strict guidelines for viral clearance, further emphasizing the importance of these technologies. As more biopharmaceuticals enter the market or undergo clinical trials, the need for virus filtration services is accelerating correspondingly, thereby driving the industry forward.

Continual advancements in technology and research

Technological advancements in the field of filtration membranes and methods are significantly impacting the growth of the virus filtration industry. Along with this, the development of more efficient, scalable, and cost-effective filtration systems is making it easier for pharmaceutical companies to integrate these solutions into their existing production lines. Innovations in nanotechnology and material science are leading to filters with higher efficacy and better throughput capabilities, thus enabling more rapid and reliable virus removal. As research and development efforts continue in filtration technology, companies operating in this domain are increasing the adoption of the technology. This technological progress elevates the standard of pharmaceutical manufacturing and serves as a strong market driver for the global market.

An enhanced focus on regulatory compliance and quality assurance

Compliance with regulatory standards is a requirement and a market driver for the virus filtration industry. Agencies have specific guidelines about the viral safety of biologically-derived medicinal products. These guidelines often necessitate multiple steps for viral clearance, including virus filtration. Meeting these regulatory expectations is paramount for pharmaceutical companies to obtain product approvals and maintain market credibility. Given the dire consequences of viral contamination, ranging from delayed product launches to legal liabilities, the emphasis on regulatory compliance acts as a compelling force for the adoption of virus filtration technologies. Moreover, the industry benefits from this heightened focus on quality assurance, making it an essential component in the biopharmaceutical manufacturing value chain.

Virus Filtration Industry Segmentation:

Breakup by Product:

Consumables
- Kits and Reagents
- Others
Instruments
- Filtration Systems
- Chromatography Systems
Services

Consumables hold the largest market share

The market for consumables in the virus filtration industry is experiencing substantial growth, driven by the recurring need for filtration consumables, such as membranes, cartridges, and cassettes in the pharmaceutical manufacturing process. Unlike capital equipment that has a long lifecycle, consumables are used in a single manufacturing cycle and need frequent replacement, ensuring a consistent demand. Furthermore, the increasing adoption of single-use technologies, particularly in bioprocessing, amplifies the need for disposable filtration consumables, which are viewed as more convenient and less prone to cross-contamination. In addition, regulatory bodies are continually tightening the guidelines for viral safety in biopharmaceutical products, which, in turn, necessitates the use of high-quality consumables that meet these stringent standards. Moreover, the growing development and manufacturing of vaccines and therapies, especially during global health crises, including pandemics, drastically increase the consumption of these disposable products.

Breakup by Application:

Biologicals
- Vaccines and Therapeutics
- Blood and Blood Products
- Cellular and Gene Therapy Products
- Others
Medical Devices
Water Purification
Air Purification
Others

Biologicals account for the majority of the market share

The biologicals segment is a key application area driving the market, primarily due to the rising demand for biotherapeutic products, such as monoclonal antibodies, vaccines, and gene therapies. These complex molecules are produced in living cells, making them vulnerable to viral contamination, thereby necessitating robust filtration processes. Along with this, regulatory scrutiny over the safety of biological products is intensifying, with agencies mandating rigorous viral clearance steps. These regulatory imperatives enforce stringent quality controls, propelling the adoption of advanced virus filtration technologies in the biologicals domain. In addition, the increasing prevalence of chronic diseases such as cancer, diabetes, and autoimmune conditions has also amplified the need for biotherapeutic treatments. Moreover, pharmaceutical companies are ramping up their production capacities and implementing state-of-the-art filtration methods to meet both consumer demand and regulatory requirements.

Breakup by End Use:

Biopharmaceuticals and Biotechnology Companies
Contract Research Organizations
Academic Institutes and Research Laboratories
Others

Biopharmaceuticals and biotechnology companies hold the largest market share

The escalating demand for biopharmaceuticals and the rapid growth of biotechnology companies serve as pivotal market drivers in the virus filtration industry. These entities are at the forefront of developing complex biological products such as monoclonal antibodies, vaccines, and recombinant proteins, which are inherently susceptible to viral contamination. Additionally, the imperative for ensuring product safety and efficacy is a scientific necessity and a regulatory mandate. In confluence with this, organizations are setting stringent guidelines that require the application of robust virus filtration processes for quality assurance. As biopharmaceuticals become increasingly central in treating a range of diseases, from chronic conditions to pandemic-related illnesses, the need for effective virus filtration grows proportionally. Furthermore, advancements in biotechnology, such as CRISPR and gene therapy, have further extended the scope and complexity of bioproducts, subsequently amplifying the necessity for advanced virus filtration solutions.

Breakup by Region:

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

North America exhibits a clear dominance, accounting for the largest virus filtration market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest segment.

The market in North America is experiencing significant growth, propelled by a favorable environment for industry expansion. One of the leading drivers is the robust presence of global biopharmaceutical companies and advanced research institutions in the region, which necessitates high-quality virus filtration solutions for product safety. Along with this, regulatory frameworks set by agencies are enforcing stringent guidelines on viral clearance, thereby elevating the demand for efficient filtration technologies. In addition, North America has been a pioneer in biotechnological advancements, contributing to the development of new therapies, vaccines, and other bioproducts that require virus filtration.

Besides this, considerable growth in the investment in healthcare research and development is substantial in this region, further fueling the growth of the market. The occurrence of global health crises, such as pandemics, often leads to a rapid scale-up in vaccine and therapeutic production, dramatically increasing the need for reliable virus filtration systems. All these elements converge to make North America a strong market for virus filtration technologies, driving both innovation and adoption in the industry.

Competitive Landscape:

The key players are continually working on developing more efficient and reliable filtration technologies. This includes innovations in filter membranes, filtration systems, and single-use technologies to provide better solutions to clients. Along with this, the major companies are offering products and services that meet or exceed these regulations, often providing robust validation support for their customers. In addition, companies are entering into strategic partnerships or acquisitions to expand their geographical reach and product portfolio. Apart from this, several brands are offering consultancy services alongside their products to help customers optimize their filtration processes, which is acting as another growth-inducing factor. With an increasing focus on environmental responsibility, some companies are exploring and developing more sustainable filtration technologies, such as reusable or recyclable filter components.

The market research report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Asahi Kasei Medical Co. Ltd.
Charles River Laboratories Inc.
Clean Cells
Danaher Corporation
Merck KGaA
Sartorius AG
Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

1.What was the size of the global virus filtration market in 2025?
2.What is the expected growth rate of the global virus filtration market during 2026-2034?
3.What are the key factors driving the global virus filtration market?
4.What has been the impact of COVID-19 on the global virus filtration market?
5.What is the breakup of the global virus filtration market based on the product?
6.What is the breakup of the global virus filtration market based on the application?
7.What is the breakup of the global virus filtration market based on the end use?
8.What are the key regions in the global virus filtration market?
9.Who are the key players/companies in the global virus filtration market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Virus Filtration Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product

6.1 Consumables
- 6.1.1 Market Trends
- 6.1.2 Major Types
  - 6.1.2.1 Kits and Reagents
  - 6.1.2.2 Others
- 6.1.3 Market Forecast
6.2 Instruments
- 6.2.1 Market Trends
- 6.2.2 Major Types
  - 6.2.2.1 Filtration Systems
  - 6.2.2.2 Chromatography Systems
- 6.2.3 Market Forecast
6.3 Services
- 6.3.1 Market Trends
- 6.3.2 Market Forecast

7 Market Breakup by Application

7.1 Biologicals
- 7.1.1 Market Trends
- 7.1.2 Major Types
  - 7.1.2.1 Vaccines and Therapeutics
  - 7.1.2.2 Blood and Blood Products
  - 7.1.2.3 Cellular and Gene Therapy Products
  - 7.1.2.4 Others
- 7.1.3 Market Forecast
7.2 Medical Devices
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Water Purification
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Air Purification
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast

8 Market Breakup by End Use

8.1 Biopharmaceuticals and Biotechnology Companies
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Contract Research Organizations
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Academic Institutes and Research Laboratories
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia-Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 Asahi Kasei Medical Co. Ltd.
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
- 14.3.2 Charles River Laboratories Inc.
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
  - 14.3.2.3 Financials
  - 14.3.2.4 SWOT Analysis
- 14.3.3 Clean Cells
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
  - 14.3.3.3 Financials
- 14.3.4 Danaher Corporation
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
  - 14.3.4.3 Financials
  - 14.3.4.4 SWOT Analysis
- 14.3.5 Merck KGaA
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
- 14.3.6 Sartorius AG
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
  - 14.3.6.3 Financials
  - 14.3.6.4 SWOT Analysis
- 14.3.7 Thermo Fisher Scientific Inc.
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
  - 14.3.7.3 Financials
  - 14.3.7.4 SWOT Analysis

簡介目錄圖表

List of Figures

Figure 1: Global: Virus Filtration Market: Major Drivers and Challenges
Figure 2: Global: Virus Filtration Market: Sales Value (in Billion USD), 2020-2025
Figure 3: Global: Virus Filtration Market Forecast: Sales Value (in Billion USD), 2026-2034
Figure 4: Global: Virus Filtration Market: Breakup by Product (in %), 2025
Figure 5: Global: Virus Filtration Market: Breakup by Application (in %), 2025
Figure 6: Global: Virus Filtration Market: Breakup by End Use (in %), 2025
Figure 7: Global: Virus Filtration Market: Breakup by Region (in %), 2025
Figure 8: Global: Virus Filtration (Consumables) Market: Sales Value (in Million USD), 2020 & 2025
Figure 9: Global: Virus Filtration (Consumables) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 10: Global: Virus Filtration (Instruments) Market: Sales Value (in Million USD), 2020 & 2025
Figure 11: Global: Virus Filtration (Instruments) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 12: Global: Virus Filtration (Services) Market: Sales Value (in Million USD), 2020 & 2025
Figure 13: Global: Virus Filtration (Services) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 14: Global: Virus Filtration (Biologicals) Market: Sales Value (in Million USD), 2020 & 2025
Figure 15: Global: Virus Filtration (Biologicals) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 16: Global: Virus Filtration (Medical Devices) Market: Sales Value (in Million USD), 2020 & 2025
Figure 17: Global: Virus Filtration (Medical Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 18: Global: Virus Filtration (Water Purification) Market: Sales Value (in Million USD), 2020 & 2025
Figure 19: Global: Virus Filtration (Water Purification) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 20: Global: Virus Filtration (Air Purification) Market: Sales Value (in Million USD), 2020 & 2025
Figure 21: Global: Virus Filtration (Air Purification) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 22: Global: Virus Filtration (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
Figure 23: Global: Virus Filtration (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 24: Global: Virus Filtration (Biopharmaceuticals and Biotechnology Companies) Market: Sales Value (in Million USD), 2020 & 2025
Figure 25: Global: Virus Filtration (Biopharmaceuticals and Biotechnology Companies) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 26: Global: Virus Filtration (Contract Research Organizations) Market: Sales Value (in Million USD), 2020 & 2025
Figure 27: Global: Virus Filtration (Contract Research Organizations) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 28: Global: Virus Filtration (Academic Institutes and Research Laboratories) Market: Sales Value (in Million USD), 2020 & 2025
Figure 29: Global: Virus Filtration (Academic Institutes and Research Laboratories) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 30: Global: Virus Filtration (Other End Uses) Market: Sales Value (in Million USD), 2020 & 2025
Figure 31: Global: Virus Filtration (Other End Uses) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 32: North America: Virus Filtration Market: Sales Value (in Million USD), 2020 & 2025
Figure 33: North America: Virus Filtration Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 34: United States: Virus Filtration Market: Sales Value (in Million USD), 2020 & 2025
Figure 35: United States: Virus Filtration Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 36: Canada: Virus Filtration Market: Sales Value (in Million USD), 2020 & 2025
Figure 37: Canada: Virus Filtration Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 38: Asia-Pacific: Virus Filtration Market: Sales Value (in Million USD), 2020 & 2025
Figure 39: Asia-Pacific: Virus Filtration Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 40: China: Virus Filtration Market: Sales Value (in Million USD), 2020 & 2025
Figure 41: China: Virus Filtration Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 42: Japan: Virus Filtration Market: Sales Value (in Million USD), 2020 & 2025
Figure 43: Japan: Virus Filtration Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 44: India: Virus Filtration Market: Sales Value (in Million USD), 2020 & 2025
Figure 45: India: Virus Filtration Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 46: South Korea: Virus Filtration Market: Sales Value (in Million USD), 2020 & 2025
Figure 47: South Korea: Virus Filtration Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 48: Australia: Virus Filtration Market: Sales Value (in Million USD), 2020 & 2025
Figure 49: Australia: Virus Filtration Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 50: Indonesia: Virus Filtration Market: Sales Value (in Million USD), 2020 & 2025
Figure 51: Indonesia: Virus Filtration Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 52: Others: Virus Filtration Market: Sales Value (in Million USD), 2020 & 2025
Figure 53: Others: Virus Filtration Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 54: Europe: Virus Filtration Market: Sales Value (in Million USD), 2020 & 2025
Figure 55: Europe: Virus Filtration Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 56: Germany: Virus Filtration Market: Sales Value (in Million USD), 2020 & 2025
Figure 57: Germany: Virus Filtration Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 58: France: Virus Filtration Market: Sales Value (in Million USD), 2020 & 2025
Figure 59: France: Virus Filtration Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 60: United Kingdom: Virus Filtration Market: Sales Value (in Million USD), 2020 & 2025
Figure 61: United Kingdom: Virus Filtration Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 62: Italy: Virus Filtration Market: Sales Value (in Million USD), 2020 & 2025
Figure 63: Italy: Virus Filtration Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 64: Spain: Virus Filtration Market: Sales Value (in Million USD), 2020 & 2025
Figure 65: Spain: Virus Filtration Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 66: Russia: Virus Filtration Market: Sales Value (in Million USD), 2020 & 2025
Figure 67: Russia: Virus Filtration Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 68: Others: Virus Filtration Market: Sales Value (in Million USD), 2020 & 2025
Figure 69: Others: Virus Filtration Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 70: Latin America: Virus Filtration Market: Sales Value (in Million USD), 2020 & 2025
Figure 71: Latin America: Virus Filtration Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 72: Brazil: Virus Filtration Market: Sales Value (in Million USD), 2020 & 2025
Figure 73: Brazil: Virus Filtration Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 74: Mexico: Virus Filtration Market: Sales Value (in Million USD), 2020 & 2025
Figure 75: Mexico: Virus Filtration Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 76: Others: Virus Filtration Market: Sales Value (in Million USD), 2020 & 2025
Figure 77: Others: Virus Filtration Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 78: Middle East and Africa: Virus Filtration Market: Sales Value (in Million USD), 2020 & 2025
Figure 79: Middle East and Africa: Virus Filtration Market: Breakup by Country (in %), 2025
Figure 80: Middle East and Africa: Virus Filtration Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 81: Global: Virus Filtration Industry: SWOT Analysis
Figure 82: Global: Virus Filtration Industry: Value Chain Analysis
Figure 83: Global: Virus Filtration Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Virus Filtration Market: Key Industry Highlights, 2025 and 2034
Table 2: Global: Virus Filtration Market Forecast: Breakup by Product (in Million USD), 2026-2034
Table 3: Global: Virus Filtration Market Forecast: Breakup by Application (in Million USD), 2026-2034
Table 4: Global: Virus Filtration Market Forecast: Breakup by End Use (in Million USD), 2026-2034
Table 5: Global: Virus Filtration Market Forecast: Breakup by Region (in Million USD), 2026-2034
Table 6: Global: Virus Filtration Market: Competitive Structure
Table 7: Global: Virus Filtration Market: Key Players

02-2729-4219

+886-2-2729-4219